Astrana Health, Inc. Proceeds from Sale and Maturity of Marketable Securities
Astrana Health, Inc. (ASTH) reported Proceeds from Sale and Maturity of Marketable Securities of $124.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2025-03-14
- Astrana Health, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Astrana Health, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2023-12-31 was $491.00K, a 98.05% decline year-over-year.
- Astrana Health, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2023-09-30 was $0.00.
- Astrana Health, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2022-12-31 was $25.23M, a 62.06% decline year-over-year.
- Astrana Health, Inc. proceeds from sale and maturity of marketable securities for fiscal 2024 was $124.00K, a 74.75% decline from fiscal 2023.
- Astrana Health, Inc. proceeds from sale and maturity of marketable securities for fiscal 2023 was $491.00K, a 98.45% decline from fiscal 2022.
- Astrana Health, Inc. proceeds from sale and maturity of marketable securities for fiscal 2022 was $31.67M, a 53.16% decline from fiscal 2021.
- Astrana Health, Inc. proceeds from sale and maturity of marketable securities for fiscal 2021 was $67.61M, a 33.55% increase from fiscal 2020.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 2 month | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $124.00K 10-K · filed 2025-03-14 | |||
| 2024-09-30 | $124.00K 10-Q · filed 2024-11-12 | ||||
| 2023-12-31 | $491.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $491.00K derived: sum of 2 quarters · filed 2025-03-14 | $491.00K 10-K · filed 2025-03-14 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | ||||
| 2022-12-31 | $25.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $25.19M derived: sum of 2 quarters · filed 2025-03-14 | $31.67M derived: sum of 3 quarters · filed 2025-03-14 | $31.67M 10-K · filed 2025-03-14 | |
| 2022-09-30 | -$42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $6.44M derived: sum of 2 quarters · filed 2023-11-09 | $6.44M 10-Q · filed 2023-11-09 | $72.94M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $6.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $6.48M 10-Q · filed 2023-08-09 | $72.99M derived: sum of 3 quarters · filed 2024-02-29 | $72.99M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | $66.51M derived: sum of 2 quarters · filed 2024-02-29 | $66.51M derived: sum of 3 quarters · filed 2024-02-29 | $66.51M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $66.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $66.51M derived: sum of 2 quarters · filed 2024-02-29 | $66.51M derived: sum of 3 quarters · filed 2024-02-29 | $67.61M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $1.11M 10-Q · filed 2022-11-07 | $51.73M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.11M 10-Q · filed 2022-08-09 | $51.73M derived: sum of 3 quarters · filed 2023-08-09 | $51.73M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2021-03-31 | $1.11M 10-Q · filed 2022-05-10 | $51.73M derived: sum of 2 quarters · filed 2023-08-09 | $51.73M derived: sum of 3 quarters · filed 2023-08-09 | ||
| 2020-12-31 | $50.63M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-08-09 | $50.63M derived: sum of 2 quarters · filed 2023-08-09 | $50.63M 10-K/A · filed 2023-08-09 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $0.00 10-Q · filed 2021-11-05 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-06 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-15 | ||||
| 2016-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-29 | $0.00 10-K · filed 2016-06-29 | |||
| 2015-12-31 | $0.00 10-Q · filed 2016-02-16 | ||||
| 2015-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-29 | $438.88K 10-K · filed 2016-06-29 | |||
| 2014-12-31 | $438.88K 10-Q · filed 2016-02-16 | ||||
| 2014-03-31 | $0.00 10-K · filed 2015-07-14 | ||||
| 2014-01-31 | $0.00 10-K · filed 2015-07-14 | ||||
| 2013-12-31 | $0.00 10-Q · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |
| TSS, Inc. (TSSI) | United States | $0.288B | 24.06 |
| Information Services Group Inc. (III) | United States | $0.256B | 16.97 |
| HACKETT GROUP, INC. (HCKT) | United States | $0.254B |